Bio-Techne
TECH
#1410
Rank
NZ$20.60 B
Marketcap
$129.89
Share price
5.03%
Change (1 day)
8.17%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of June 2024 : NZ$3.34 B

According to Bio-Techne's latest financial reports the company has NZ$3.34 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$NZ$3.20 B17.88%
2022-06-30$NZ$2.71 B20.88%
2021-06-30$NZ$2.24 B5.01%
2020-06-30$NZ$2.14 B23.57%
2019-06-30$NZ$1.73 B8.82%
2018-06-30$NZ$1.59 B22.84%
2017-06-30$NZ$1.29 B4.81%
2016-06-30$NZ$1.23 B0.47%
2015-06-30$NZ$1.23 B35.95%
2014-06-30$NZ$0.90 B-4.87%
2013-06-30$NZ$0.95 B13.33%
2012-06-30$NZ$0.84 B18.03%
2011-06-30$NZ$0.71 B-1.72%
2010-06-30$NZ$0.72 B3.25%
2009-06-30$NZ$0.70 B9.58%
2008-06-30$NZ$0.64 B12.47%
2007-06-30$NZ$0.56 B1.31%
2006-06-30$NZ$0.56 B46.68%
2005-06-30$NZ$0.38 B-18.77%
2004-06-30$NZ$0.47 B16.05%
2003-06-30$NZ$0.40 B-4.36%
2002-06-30$NZ$0.42 B-2.76%
2001-06-30$NZ$0.43 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$76.83 B 2,197.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.95 B 227.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$41.81 B 1,150.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$80.66 B 2,312.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.50 B 64.60%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$30.45 B 810.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 B-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA